Amrutanjan Health Care Limited (AHCL) has announced the record date for its first interim dividend for the financial year 2025-26. This development comes as part of the company's recent board meeting decisions, which also included the approval of unaudited financial results for the quarter and half-year ended September 30, 2025.

Key Details of the Dividend Announcement

The company has fixed November 18, 2025, as the record date for the payment of the first interim dividend. Shareholders whose names appear in the register of members and as beneficial owners in the records of National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) on the record date will be eligible for the dividend.

Board Meeting Outcomes

The Board of Directors of Amrutanjan Health Care Limited convened on November 10, 2025, and made several key decisions:

1. Approved the unaudited financial results for Q2 and H1 of FY 2025-26
2. Declared the first interim dividend of Re. 1/- per share
3. The board meeting commenced at 12:00 PM and concluded at 4:30 PM

Financial Performance Highlights

The company's financial results for the quarter ended September 30, 2025, showcase its performance:

The company has shown growth in both revenue and profitability compared to the same quarter in the previous fiscal year.

Compliance and Disclosure

In compliance with regulatory requirements, Amrutanjan Health Care Limited has informed both the National Stock Exchange of India Limited (NSE) and BSE Limited about these decisions. The company adheres to the regulations set forth by the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements.

Investors and shareholders are advised to take note of the record date to ensure their eligibility for receiving the interim dividend. As always, it is recommended that investors consult with their financial advisors before making any investment decisions based on this information.

Amrutanjan Health Care Limited has announced strong financial results for the second quarter, demonstrating significant growth across key metrics.

Financial Highlights

The company's performance for Q2 shows impressive year-over-year improvements:

Performance Analysis

Amrutanjan Health Care has demonstrated robust growth in the second quarter, with net profit rising by 18.4% year-over-year to ₹139.60 crore. This significant increase in profitability was accompanied by a 7.1% growth in revenue, which reached ₹1,177.00 crore for the quarter.

The company's operational efficiency has also shown marked improvement, as evidenced by the EBITDA growth of 21.5% to ₹165.20 crore. The EBITDA margin expanded by 166 basis points to 14.04%, indicating enhanced operational performance and cost management.

Corporate Actions

In addition to the quarterly results, Amrutanjan Health Care's Board of Directors has declared a first interim dividend of ₹1 per share. The company has set November 18, 2025, as the record date for dividend payment.

Outlook

The company's ability to grow its revenue while simultaneously expanding its profit margins suggests a positive trajectory for Amrutanjan Health Care. The improved EBITDA margin indicates that the company is effectively managing its costs while driving growth, which could bode well for future performance.

Investors and market observers will likely keep a close watch on Amrutanjan Health Care's performance in the coming quarters to see if this growth momentum can be sustained, especially in light of broader economic conditions and industry trends.

As always, stakeholders are advised to consider these results in the context of broader market conditions and to consult with financial advisors before making investment decisions.